Posttranslational modifications (PTMs) on histone tails spatiotemporally dictate mammalian neural stem cell (NSC) fate. Bone morphogenetic protein 4 (BMP4), a member of the transforming growth factor β (TGF-β) superfamily, suppresses NSC proliferation and fosters differentiation into astroglial cells. Whether PTMs mediate these effects of BMP4 is unknown. Here we demonstrate that BMP4 signaling causes a net reduction in cellular histone H3 lysine 4 trimethylation (H3K4me3), an active histone mark at promoters of genes associated with human NSC proliferation. We also show that H3K4me3 reduction by BMP4 is mediated by decreased expression of SETD1A and WDR82, two methyltransferase components of SETD1A-COMPASS.
INTRODUCTION
Neural stem cells (NSCs) either self-renew or differentiate into neurons, astrocytes and oligodendrocytes [1, 2] . Higher order chromatin structure precisely regulates gene expression to dictate NSC fate [3, 4] . Histones are key components of chromatin and subject to a wide variety of dynamic post-translational modifications (PTMs) [5] . Histone and associated modifications are important determinants of human NSC self-renewal, proliferation and differentiation [4, [6] [7] [8] [9] .
Trimethylation of histone H3 lysine 4 (H3K4me3) by a complex of proteins associated with SET1A/B (SETD1A/B-COMPASS) [10] [11] [12] , is pivotal in determining human NSC fate [13] [14] [15] [16] [17] .
H3K4me3 is enriched near transcription start sites (TSSs) at the 5' regions of virtually all activelyexpressed genes; its presence has a strong positive correlation with gene transcription rates, polymerase II promoter occupancy [18, 19] , and transcriptional consistency [20] . WDR82 is a specific subunit of SETD1A/B. Other subunits of SETD1A/B-COMPASS include WDR5 [21] , DPY30 [22] , and ASH2L [23] .
Bone morphogenetic protein 4 (BMP4), a member of the TGF-β superfamily, is essential for central nervous system (CNS) development due to its influence on NSC self-renewal, proliferation and differentiation [24] . BMP4 signaling affects the expression of key genes that affect NSC fate.
For example, BMP4 increases CXXC finger protein 5 (CXXC5) to repress Wnt signaling and promote NSC differentiation [25] . It increases expression of inhibitor of differentiation 4 (ID4) and ID2, which inhibits oligodendroglial lineage commitment and promotes astrocyte commitment [26] .
BMP4 inhibits mitogen-activated protein kinase (MAPK) pathways that support stem cell selfrenewal [27] , and it stimulates msx2 and p21 to mediate pro-apoptotic effects on NPCs in the ventricular zone [28] .
However, little is known regarding effects of BMP4 on chromatin structure and how these changes influence gene expression. BMP4 differentiates CD133-positive glioma stem cells to astrogliallike cells [29] and inhibits their proliferation through decreasing CYCLIN D1 expression [30] .
SMAD-mediated BMP4 signaling regulates embryonic stem cell proliferation by altering H3K4me3 enrichment at promoters of proliferation genes [31] . In NSCs, the CYCLIN D1 promoter is enriched for H3K4me3 [20] . We found that Human StemPro® NSCs are CD133 positive which led to the hypothesis that BMP4 inhibits human StemPro® NSC proliferation through reduction of H3K4me3 at the CYCLIN D1 gene. In this study we show that BMP4 signaling regulates H3K4me3 and chromatin structure, thereby influencing expression of several genes with important consequences for NSC differentiation and proliferation.
MATERIAL AND METHODS

Reagents and antibodies
Knockout TM DMEM/F-12(Cat#12660-012), StemPro® neural supplement (Cat#A10508-01), epidermal growth factor (EGF), fibroblast growth factor-2 (FGF-2), GlutaMAX™-I CTS™ (100X) (Cat#A12860), Geltrex® hESC-qualified Reduced Growth Factor Basement Membrane Matrix (Cat# A1413301), StemPro® Accutase® Cell Dissociation Reagent (Cat#A11105), and Geltrex® LDEV-Free hESC-qualified Reduced Growth Factor Basement Membrane Matrix (Cat#A14133) were purchased from Life Technologies (Frederick, MD, USA). Accutase was purchased from Millipore (Billerica, MA, USA). Heparin (Cat#H3149) and ascorbic acid (Cat#A8960) were from Sigma Aldrich (St. Louis, MO, USA).
Rabbit polyclonal antibody against WDR82 was a generous gift from Dr. David G. Skalnik (Indiana University School of Medicine, IN, USA). Antibodies were purchased from the following companies: BMP4 (sc-6896), OCT4 (sc-8629), and GAPDH (sc-25778) from Santa Cruz Biotechnology (Dallas, TX, USA); human SETD1A (Cat#A300-289A) and SETD1B (Cat#302-280A) from Bethyl Laboratories (Montgomery, TX, USA); H3K4me3 (Cat#9727), Histone H3 (Cat#9715), ASH2L (Cat#5019); WDR5 (Cat#13105), RBBP5 (Cat#13171), and CYCLIN D1 (Cat#2922) from Cell Signaling Technology; CD133 (ab5558), and β-actin (ab-8227) from Abcam (Cambridge, MA, USA).
Immunohistochemistry
Formalin-fixed, paraffin-embedded (FFPE) fetal brain tissue slides containing lateral ventricle lining from autopsy brain samples, from two pediatric patients who died of non-brain related diseases, were obtained from the Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago. FFPE slides were de-paraffinized in xylene, and hydrated through a graded series of alcohols. Endogenous peroxidases were blocked with 3% hydrogen peroxide. Antigen retrieval was performed by boiling for 20 min in a 0.01 M sodium citrate (pH 6.0) solution and endogenous biotin was blocked using the Avidin/Biotin Blocking Kit (Vector Labs, SP-2001).
Slides were incubated overnight with primary antibodies against anti-rabbit H3K4me3 (Cell Signaling Technology, Cat#9727, 1:400). Following incubation with biotin-labeled secondary antibodies (Vector Laboratories BA1000), antigens were visualized with streptavidin-biotin (Vectastain Elite ABC kit; Vector Laboratories) followed by Vector ® NovaRED™ (Vector Laboratories) and counterstained with hematoxylin (Richard-Allen Scientific). Images were captured on a Leica DMR-HC upright microscope and analyzed using OpenLab 5.0 software.
Cell culture: primary neurospheres, spontaneously differentiated cells and human astrocytes
Human StemPro® NSC line derived from fetal brain was purchased from Life Technologies, Inc. manufacturer's instruction. The cells were re-suspended in differentiation medium prior to plating on Geltrex® matrix-coated culture vessels, and grown with SFM without bFGF and EGF. The medium was changed after 2 days followed by replacement of half of the media every 2-3 days.
Following 7 days of differentiation, all three neural lineages (astrocytes, neurons, and oligodendrocytes) were present. The normal human astrocyte cell line (HA) was kindly provided by Dr. Rintaro Hashizume and grown as described [32, 33] .
Immunofluorescence
Seven days after primary neurospheres culture, cells were harvested as single cells and split with SFM or differentiation medium. For sphere staining, spheres were plated onto glass coverslips coated with Geltrex® matrix placed in individual wells of a 12-well culture plate in SFM and monitored under a microscope every 15mins. Once spheres attached and began to differentiate they were fixed with 4% paraformaldehyde in PBS (Pierce Chemical Co., Rockford, IL). For staining of differentiated cells, cells were plated onto glass coverslips coated with Geltrex® matrix, and cultured in individual wells of a 12-well culture plate with SF differentiation medium. Seven days after plating, coverslips were fixed with 4% paraformaldehyde in PBS. Fixed cells were blocked with 10% donkey serum and 0.3% Triton X-100 in PBS and incubated with CD133 (1:100), OCT3/4 (1:100), SOX2 (1:100), and NESTIN (1:100) for neurospheres; and with MUSHASHI 
Constructs and transfections
pcDNA3-WDR82-HA was a generous gift from Dr. David G. Skalnik (Indiana University School of Medicine, IN, USA). pcDNA3-HA was a gift from Kunliang Guan (Addgene plasmid #13512).
Human His-tagged SETD1A expression pET28-SETD1A-MHL plasmid and its control pET28-MHL were gifts from Cheryl Arrowsmith (Addgene plasmid # 32868 and #26096, respectively). 
Neurosphere formation, cell proliferation and differentiation assays
Human StemPro® NSCs were harvested as single cells and plated on 12-well plates at 8.33 × 10 4 cells/well and treated with 100ng/ml BMP4, or with buffer. Sphere formation was monitored daily and the number of spheres was counted 4 days after treatment. At 4 days the spheres were centrifuged and dissociated with StemPro® Accutase® into single cells. The cells were resuspended in 1ml NSC SFM and counted with a hemocytometer. Sphere and cell numbers from triplicate wells were counted and analyzed. For sphere differentiation assays, human StemPro® NSCs were harvested as single cells and plated on 6-well plates at a density of 4.5 × 10 5 cells/well. Sphere formation was monitored daily. On day 4 after plating, the spheres were treated with 100ng/ml BMP4, or buffer. Sphere differentiation was investigated daily for 7 days and cells were harvested for RNA extraction for PCR array assays.
For HA sphere formation assays, the cells were plated in 6-well plates and transfected with pET28-hSETD1A-MHL and pcDNA3-WDR82-HA using StemPro® NSC transfection reagent.
After 48 hrs, the culture medium was replaced with Neurobasal medium supplement with N2, B27, EGF 20ng/ml and bFGF 20ng/ml. At day 4, sphere numbers from a minimum of ten fields in triplicate wells were counted and analyzed.
Sphere or cell numbers were averaged and graphed with Graphpad Prism 7.0 software (La Jolla, CA, USA). P values were calculated using 2-sided Student's t test, with p<0.05 considered significant.
Quantitative real-time PCR
Total RNA was isolated with the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) from primary sphere cultures and spontaneously differentiated Human StemPro® NSCs, treated with BMP4 and from non-treated controls. cDNA was synthesized with qScript cDNA SuperMix (5 ×) (Quanta Biosciences, 95048-025) followed by real-time (RT) PCR with primers as indicated (Supplementary Table 1 ). To ensure accuracy, an internal reference reaction using GAPDH was performed on the same sample as used for the target gene. The results were standardized with the formula: ΔCT = CTRef − CTTarget and converted to fold change of target gene over reference gene (F = 2 -ΔCT ). Data from a minimum of 3 independent experiments were used to quantify gene expression. P values of less than 0.05 were considered statistically significant. 
Protein extraction and western blots
RESULTS
H3K4me3 is a stem marker for human NSCs
Slides from the region lining the lateral ventricle were prepared from two human fetal brain samples and immunostained for H3K4me3. H3K4me3 positive cells were enriched in the SVZ ( Figure 1A ), in agreement with previous findings from rodents [34] and baboons [13] . To determine if H3K4me3 and its methyltransferases hSETD1A and WDR82 were altered upon differentiation, RNA, total protein, and histones were extracted from spheres and from differentiated human NSCs (StemPro®). Real-time PCR and western blots both showed that hSETD1A and WDR82 expression was higher in sphere cultured cells compared to differentiated cells ( Figure 1C and D) . Other proteins included in the hSETD1A-COMPASS complex were not significantly changed ( Supplementary Figure 1) . H3K4me3 was readily detected in undifferentiated sphere-cultured hNSCs, but was undetectable in differentiated cells ( Figure 1D ).
These results indicate that H3K4me3 and the activity of its methyltransferases hSETD1A and WDR82 are associated with NSC self-renewal, but not with differentiated cells.
H3K4me3 promoter occupancy determines hNSC fate
We examined the expression of OCT4 [35] , a crucial stem cell self-renewal marker, and NESTIN, a neural stem/progenitor marker, for potential relationships with H3K4 methylation. Both were expressed in NSCs, with decreased expression in spontaneously differentiated cells, (Figure 2 A-E). Using H3K4me3 ChIP coupled with real-time PCR ( Figure 2F ) we determined that H3K4me3 is enriched at OCT4 and NESTIN promoters in undifferentiated hNSCs relative to their differentiated derivatives ( Figure 2F ).
BMP4 decreases H3K4me3 at CCND1 promoter in differentiated hNSCs
To determine whether BMP4 inhibits human StemPro® NSCs proliferation through reduction of H3K4me3 at the CYCLIN D1 gene, hNSC neurospheres were cultured in 100ng/ml BMP4 ( Figure   3A ), which reduced both the number of neurospheres (diameter >250μm) ( Figure 3B and C) and the overall number of cells ( Figure 3D ). BMP4 reduced CYCLIN D1 expression ( Figure 3F and G) and CYCLIN D1 promoter H3K4me3 occupancy ( Figure 3H ). 
BMP4 reduces H3K4me3 at the NESTIN promoter and promotes hNSC differentiation
We monitored differentiation of neurospheres from hNSCs following treatment with 100ng/ml BMP4 vs untreated controls ( Figure 4A ). By the fourth day nearly all neurospheres treated with BMP4 had attached and migrated ( Figure 4B ). Additionally, H3K4me3 markedly decreased in the treatment group compared to the controls ( Figure 4C ). NESTIN expression, examined by real- time PCR ( Figure 4D ) and western blot ( Figure 4E ), showed significant decreases with BMP4 treatment, as did levels of H3K4me3 at the NESTIN promoter ( Figure 4F ).
BMP4 reduces SETD1A and WDR82 expression, with a corresponding reduction in cellular H3K4me3
BMP4 reduced levels of WDR82 and human SETD1A levels ( Figure 5A ). To determine the biologic effects in NSCs of reduced SETD1A and WDR82, hNSCs were incubated with SETD1A siRNA or transduced with lentivirus expressing WDR82 shRNA. Both treatments decreased sphere numbers in comparison to controls ( Figure 5B ). Target transcripts as well as transcripts associated with stemness (OCT4 and NESTIN) and proliferation (CCND1) also decreased ( Figure   5C and D). H3K4me3 chromatin immunoprecipitation coupled with real-time PCR revealed that Figure 5E ).
Ectopic expression of SETD1A and WDR82 increases expression of stemness and proliferation genes in normal human astrocytes
We investigated whether increasing expression of WDR82 or hSETD1A in human astrocytes (HAs) promotes cellular dedifferentiation. When astrocytes were transfected with WDR82 or hSETD1A cDNA, and cultured in hNSC medium for 4 days, sphere numbers increased ( Figure   6A ), as did expression of OCT4, CCND1 and NESTIN, indicated by real-time PCR and western 
DISSCUSSION
BMP4 is critical for nervous system development due to its influence over several biological processes, ranging from dorsoventral patterning of the embryonic neural tube to proliferation, apoptosis, neurogenesis, and gliogenesis at different stages and locations [36] [37] [38] . BMP4 also plays important roles in the regulation of neural progenitor cell fate and promotes neuronal precursor differentiation in the spinal cord [39] and cortex [40] . Here we found that cellular H3K4me3 and its methyltransferases hSETD1A and WDR82 decrease upon BMP4-induced hNSC differentiation. This differentiation is accompanied by decreased expression of stem cell signature proteins OCT4 and NESTIN, in conjunction with decreased H3K4me3 at their promoters.
We also showed that BMP4 reduces proliferation of human NSCs and inhibits neurosphere formation, this may be through decreased CYCLIN D1 promoter H3K4me3 occupancy, and thus CYCLIN D1 expression. Conversely, increased expression of WDR82 and hSETD1A in normal HAs increased global H3K4me3 levels and promoter occupancy at genes associated with stemness, proliferation and differentiation of hNSCs. Collectively these findings clearly demonstrate that hSETD1A and WDR82 are critical for maintaining neural stem cell populations, and decreasing in their expression promotes cellular differentiation.
Recent studies have shown histone PTMs are essential in hNSC self-renewal and differentiation.
For example, H3K4me3 is present in undifferentiated progenitor cells within the SVZ and it is associated with distinct neurogenesis networks and pathways [13] . H3K4me3 is also required to ensure transcriptional precision at key genes during neural progenitor cell differentiation [20] . In the present study, we show that BMP4 changes H3K4me3 levels at specific loci including those involved with stemness (OCT4 and NESTIN) and proliferation CCND1 (Figures 2-4 ).
Mammalian SETD1A/B-COMPASS are responsible for H3K4me3 [41] , with SETD1A most relevant in the development and maintenance of hNSCs [42, 43] . In silico analysis results from several published databases (GSE55379, GSE53404, and GSE43382) show high levels of SETD1A in human NSCs, with decreased levels in differentiated cells ( Supplementary Figure 2A) .
In this study we show that SETD1A is high in human NSCs and decreases in differentiated cells ( Figure 1C and D) , in agreement with previous findings.
Our results show that expression of WDR82, a subunit of SETD1A-COMPASS, is also high in human NSCs, and that it decreases in differentiated cells ( Figure 1C and D) . WDR82 mediates alterations in H3K4me3 levels and in so doing influences hNSC proliferation and apoptosis during normal embryonic growth and development [44] . Analysis of results from databases GSE15209 and GSE43382 show that WDR82 is high in human NSCs, but decreases in differentiated brain cortex (GSE15209) and differentiated human NSCs (GSE43382) (Supplementary Figure 2B) . This is consistent with our results and highlights WDR82 involvement in regulating hNSC stemness and differentiation.
SETD1A acts through several mechanisms to bring about intracellular changes. Studies have shown that it modulates cell cycle progression through induction of a miRNA network to suppress P53 in human cancers [45, 46] , independent of H3K4me3. A non-catalytic domain, "FLOS" (functional location on SETD1A), interacts with CYCLIN K and regulates DNA damage response gene expression [47] . In the present study, we found reduction of WDR82 decreased hSETD1A expression in hNSCs ( Figure 5C and D) , while ectopic expression of WDR82 markedly increased SETD1A ( Figure 6B and C) in normal HAs, consistent with findings from other groups [48, 49] .
Conversely, reduction of hSETD1A decreased hNSC WDR82 expression ( Figure 5C and D) , whereas induction of SETD1A markedly increased WDR82 in normal HAs (Figure 6B and C).
WDR82 interacts with an RNA recognition motif (RRM) [48, 49] , consisting of 95 highly conserved indicate that WDR82 and hSETD1A control cellular H3K4me3 in hNSCs and suggest that BMP4 promotes hNSC differentiation through an epigenetic mechanism.
CONCLUSION
In this work, we have shown that H3K4me3 promoter occupancy mediated by hSETD1A and WDR82 is critical for hNSC fate. BMP4 decreases hSETD1A and WDR82, resulting in the reduction of H3K4me3 at key genes such as OCT4, NESTIN and CCND1 to inhibit proliferation and promote differentiation of hNSCs ( Figure 7) . These results extend our understanding of the role of histone PTMs in normal CNS development. 
